世界の急性肺損傷（ALI）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Lung Injury Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0064 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、急性肺損傷（ALI）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、人工呼吸器、補助的処置、輸液管理、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・急性肺損傷（ALI）の市場動向 ・企業の競争状況、市場シェア ・急性肺損傷（ALI）の種類別市場規模（薬物療法、人工呼吸器、補助的処置、輸液管理、その他） ・急性肺損傷（ALI）の用途別市場規模（病院、クリニック、その他） ・急性肺損傷（ALI）の北米市場規模2016-2027（アメリカ、カナダ） ・急性肺損傷（ALI）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性肺損傷（ALI）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性肺損傷（ALI）の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性肺損傷（ALI）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Altor BioScience、FirstString Research、GlaxoSmithKline、Forschung und Entwicklung、Commence Bio、CompleGen、Histocell S.L.、Stemedica Cell Technologies、Windtree Therapeutics、S-Evans Biosciences） ・結論

Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema.

Market Analysis and Insights: Global Acute Lung Injury Market
The global Acute Lung Injury market size is projected to reach US$ 722.9 million by 2026, from US$ 516.7 million in 2019, at a CAGR of 4.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Lung Injury market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Lung Injury market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Lung Injury market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Lung Injury market.

Global Acute Lung Injury Scope and Market Size
Acute Lung Injury market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Lung Injury market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pharmacotherapy
Mechanical Ventilation
Adjunctive Procedures
Fluid Management
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Altor BioScience
FirstString Research
GlaxoSmithKline
Forschung und Entwicklung
Commence Bio
CompleGen
Histocell S.L.
Stemedica Cell Technologies
Windtree Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Lung Injury Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmacotherapy
1.2.3 Mechanical Ventilation
1.2.4 Adjunctive Procedures
1.2.5 Fluid Management
1.2.6 Others
1.3 Market by Application
1.3.1 Global Acute Lung Injury Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Lung Injury Market Perspective (2016-2027)
2.2 Acute Lung Injury Growth Trends by Regions
2.2.1 Acute Lung Injury Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Lung Injury Historic Market Share by Regions (2016-2021)
2.2.3 Acute Lung Injury Forecasted Market Size by Regions (2022-2027)
2.3 Acute Lung Injury Industry Dynamic
2.3.1 Acute Lung Injury Market Trends
2.3.2 Acute Lung Injury Market Drivers
2.3.3 Acute Lung Injury Market Challenges
2.3.4 Acute Lung Injury Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Lung Injury Players by Revenue
3.1.1 Global Top Acute Lung Injury Players by Revenue (2016-2021)
3.1.2 Global Acute Lung Injury Revenue Market Share by Players (2016-2021)
3.2 Global Acute Lung Injury Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Lung Injury Revenue
3.4 Global Acute Lung Injury Market Concentration Ratio
3.4.1 Global Acute Lung Injury Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Lung Injury Revenue in 2020
3.5 Acute Lung Injury Key Players Head office and Area Served
3.6 Key Players Acute Lung Injury Product Solution and Service
3.7 Date of Enter into Acute Lung Injury Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Lung Injury Breakdown Data by Type
4.1 Global Acute Lung Injury Historic Market Size by Type (2016-2021)
4.2 Global Acute Lung Injury Forecasted Market Size by Type (2022-2027)

5 Acute Lung Injury Breakdown Data by Application
5.1 Global Acute Lung Injury Historic Market Size by Application (2016-2021)
5.2 Global Acute Lung Injury Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Lung Injury Market Size (2016-2027)
6.2 North America Acute Lung Injury Market Size by Type
6.2.1 North America Acute Lung Injury Market Size by Type (2016-2021)
6.2.2 North America Acute Lung Injury Market Size by Type (2022-2027)
6.2.3 North America Acute Lung Injury Market Size by Type (2016-2027)
6.3 North America Acute Lung Injury Market Size by Application
6.3.1 North America Acute Lung Injury Market Size by Application (2016-2021)
6.3.2 North America Acute Lung Injury Market Size by Application (2022-2027)
6.3.3 North America Acute Lung Injury Market Size by Application (2016-2027)
6.4 North America Acute Lung Injury Market Size by Country
6.4.1 North America Acute Lung Injury Market Size by Country (2016-2021)
6.4.2 North America Acute Lung Injury Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Lung Injury Market Size (2016-2027)
7.2 Europe Acute Lung Injury Market Size by Type
7.2.1 Europe Acute Lung Injury Market Size by Type (2016-2021)
7.2.2 Europe Acute Lung Injury Market Size by Type (2022-2027)
7.2.3 Europe Acute Lung Injury Market Size by Type (2016-2027)
7.3 Europe Acute Lung Injury Market Size by Application
7.3.1 Europe Acute Lung Injury Market Size by Application (2016-2021)
7.3.2 Europe Acute Lung Injury Market Size by Application (2022-2027)
7.3.3 Europe Acute Lung Injury Market Size by Application (2016-2027)
7.4 Europe Acute Lung Injury Market Size by Country
7.4.1 Europe Acute Lung Injury Market Size by Country (2016-2021)
7.4.2 Europe Acute Lung Injury Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Lung Injury Market Size (2016-2027)
8.2 Asia-Pacific Acute Lung Injury Market Size by Type
8.2.1 Asia-Pacific Acute Lung Injury Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Lung Injury Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Lung Injury Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Lung Injury Market Size by Application
8.3.1 Asia-Pacific Acute Lung Injury Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Lung Injury Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Lung Injury Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Lung Injury Market Size by Region
8.4.1 Asia-Pacific Acute Lung Injury Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Lung Injury Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Lung Injury Market Size (2016-2027)
9.2 Latin America Acute Lung Injury Market Size by Type
9.2.1 Latin America Acute Lung Injury Market Size by Type (2016-2021)
9.2.2 Latin America Acute Lung Injury Market Size by Type (2022-2027)
9.2.3 Latin America Acute Lung Injury Market Size by Type (2016-2027)
9.3 Latin America Acute Lung Injury Market Size by Application
9.3.1 Latin America Acute Lung Injury Market Size by Application (2016-2021)
9.3.2 Latin America Acute Lung Injury Market Size by Application (2022-2027)
9.3.3 Latin America Acute Lung Injury Market Size by Application (2016-2027)
9.4 Latin America Acute Lung Injury Market Size by Country
9.4.1 Latin America Acute Lung Injury Market Size by Country (2016-2021)
9.4.2 Latin America Acute Lung Injury Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Lung Injury Market Size (2016-2027)
10.2 Middle East & Africa Acute Lung Injury Market Size by Type
10.2.1 Middle East & Africa Acute Lung Injury Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Lung Injury Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Lung Injury Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Lung Injury Market Size by Application
10.3.1 Middle East & Africa Acute Lung Injury Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Lung Injury Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Lung Injury Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Lung Injury Market Size by Country
10.4.1 Middle East & Africa Acute Lung Injury Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Lung Injury Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Altor BioScience
11.1.1 Altor BioScience Company Details
11.1.2 Altor BioScience Business Overview
11.1.3 Altor BioScience Acute Lung Injury Introduction
11.1.4 Altor BioScience Revenue in Acute Lung Injury Business (2016-2021)
11.1.5 Altor BioScience Recent Development
11.2 FirstString Research
11.2.1 FirstString Research Company Details
11.2.2 FirstString Research Business Overview
11.2.3 FirstString Research Acute Lung Injury Introduction
11.2.4 FirstString Research Revenue in Acute Lung Injury Business (2016-2021)
11.2.5 FirstString Research Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Acute Lung Injury Introduction
11.3.4 GlaxoSmithKline Revenue in Acute Lung Injury Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Forschung und Entwicklung
11.4.1 Forschung und Entwicklung Company Details
11.4.2 Forschung und Entwicklung Business Overview
11.4.3 Forschung und Entwicklung Acute Lung Injury Introduction
11.4.4 Forschung und Entwicklung Revenue in Acute Lung Injury Business (2016-2021)
11.4.5 Forschung und Entwicklung Recent Development
11.5 Commence Bio
11.5.1 Commence Bio Company Details
11.5.2 Commence Bio Business Overview
11.5.3 Commence Bio Acute Lung Injury Introduction
11.5.4 Commence Bio Revenue in Acute Lung Injury Business (2016-2021)
11.5.5 Commence Bio Recent Development
11.6 CompleGen
11.6.1 CompleGen Company Details
11.6.2 CompleGen Business Overview
11.6.3 CompleGen Acute Lung Injury Introduction
11.6.4 CompleGen Revenue in Acute Lung Injury Business (2016-2021)
11.6.5 CompleGen Recent Development
11.7 Histocell S.L.
11.7.1 Histocell S.L. Company Details
11.7.2 Histocell S.L. Business Overview
11.7.3 Histocell S.L. Acute Lung Injury Introduction
11.7.4 Histocell S.L. Revenue in Acute Lung Injury Business (2016-2021)
11.7.5 Histocell S.L. Recent Development
11.8 Stemedica Cell Technologies
11.8.1 Stemedica Cell Technologies Company Details
11.8.2 Stemedica Cell Technologies Business Overview
11.8.3 Stemedica Cell Technologies Acute Lung Injury Introduction
11.8.4 Stemedica Cell Technologies Revenue in Acute Lung Injury Business (2016-2021)
11.8.5 Stemedica Cell Technologies Recent Development
11.9 Windtree Therapeutics
11.9.1 Windtree Therapeutics Company Details
11.9.2 Windtree Therapeutics Business Overview
11.9.3 Windtree Therapeutics Acute Lung Injury Introduction
11.9.4 Windtree Therapeutics Revenue in Acute Lung Injury Business (2016-2021)
11.9.5 Windtree Therapeutics Recent Development
11.10 S-Evans Biosciences
11.10.1 S-Evans Biosciences Company Details
11.10.2 S-Evans Biosciences Business Overview
11.10.3 S-Evans Biosciences Acute Lung Injury Introduction
11.10.4 S-Evans Biosciences Revenue in Acute Lung Injury Business (2016-2021)
11.10.5 S-Evans Biosciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Lung Injury Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pharmacotherapy
Table 3. Key Players of Mechanical Ventilation
Table 4. Key Players of Adjunctive Procedures
Table 5. Key Players of Fluid Management
Table 6. Key Players of Others
Table 7. Global Acute Lung Injury Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Lung Injury Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Acute Lung Injury Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Acute Lung Injury Market Share by Regions (2016-2021)
Table 11. Global Acute Lung Injury Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Acute Lung Injury Market Share by Regions (2022-2027)
Table 13. Acute Lung Injury Market Trends
Table 14. Acute Lung Injury Market Drivers
Table 15. Acute Lung Injury Market Challenges
Table 16. Acute Lung Injury Market Restraints
Table 17. Global Acute Lung Injury Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Acute Lung Injury Market Share by Players (2016-2021)
Table 19. Global Top Acute Lung Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Lung Injury as of 2020)
Table 20. Ranking of Global Top Acute Lung Injury Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Acute Lung Injury Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acute Lung Injury Product Solution and Service
Table 24. Date of Enter into Acute Lung Injury Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Lung Injury Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Acute Lung Injury Revenue Market Share by Type (2016-2021)
Table 28. Global Acute Lung Injury Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Acute Lung Injury Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Acute Lung Injury Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Acute Lung Injury Revenue Market Share by Application (2016-2021)
Table 32. Global Acute Lung Injury Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Acute Lung Injury Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Acute Lung Injury Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Acute Lung Injury Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Acute Lung Injury Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Acute Lung Injury Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Acute Lung Injury Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Acute Lung Injury Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Acute Lung Injury Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Acute Lung Injury Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Acute Lung Injury Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Acute Lung Injury Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Acute Lung Injury Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Acute Lung Injury Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Lung Injury Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Lung Injury Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Lung Injury Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acute Lung Injury Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acute Lung Injury Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Acute Lung Injury Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Acute Lung Injury Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Acute Lung Injury Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Acute Lung Injury Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Acute Lung Injury Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Acute Lung Injury Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Acute Lung Injury Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Lung Injury Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Lung Injury Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Lung Injury Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acute Lung Injury Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acute Lung Injury Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Acute Lung Injury Market Size by Country (2022-2027) & (US$ Million)
Table 64. Altor BioScience Company Details
Table 65. Altor BioScience Business Overview
Table 66. Altor BioScience Acute Lung Injury Product
Table 67. Altor BioScience Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 68. Altor BioScience Recent Development
Table 69. FirstString Research Company Details
Table 70. FirstString Research Business Overview
Table 71. FirstString Research Acute Lung Injury Product
Table 72. FirstString Research Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 73. FirstString Research Recent Development
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Acute Lung Injury Product
Table 77. GlaxoSmithKline Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Forschung und Entwicklung Company Details
Table 80. Forschung und Entwicklung Business Overview
Table 81. Forschung und Entwicklung Acute Lung Injury Product
Table 82. Forschung und Entwicklung Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 83. Forschung und Entwicklung Recent Development
Table 84. Commence Bio Company Details
Table 85. Commence Bio Business Overview
Table 86. Commence Bio Acute Lung Injury Product
Table 87. Commence Bio Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 88. Commence Bio Recent Development
Table 89. CompleGen Company Details
Table 90. CompleGen Business Overview
Table 91. CompleGen Acute Lung Injury Product
Table 92. CompleGen Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 93. CompleGen Recent Development
Table 94. Histocell S.L. Company Details
Table 95. Histocell S.L. Business Overview
Table 96. Histocell S.L. Acute Lung Injury Product
Table 97. Histocell S.L. Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 98. Histocell S.L. Recent Development
Table 99. Stemedica Cell Technologies Company Details
Table 100. Stemedica Cell Technologies Business Overview
Table 101. Stemedica Cell Technologies Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 102. Stemedica Cell Technologies Recent Development
Table 103. Windtree Therapeutics Company Details
Table 104. Windtree Therapeutics Business Overview
Table 105. Windtree Therapeutics Acute Lung Injury Product
Table 106. Windtree Therapeutics Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 107. Windtree Therapeutics Recent Development
Table 108. S-Evans Biosciences Company Details
Table 109. S-Evans Biosciences Business Overview
Table 110. S-Evans Biosciences Acute Lung Injury Product
Table 111. S-Evans Biosciences Revenue in Acute Lung Injury Business (2016-2021) & (US$ Million)
Table 112. S-Evans Biosciences Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Lung Injury Market Share by Type: 2020 VS 2027
Figure 2. Pharmacotherapy Features
Figure 3. Mechanical Ventilation Features
Figure 4. Adjunctive Procedures Features
Figure 5. Fluid Management Features
Figure 6. Others Features
Figure 7. Global Acute Lung Injury Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Lung Injury Report Years Considered
Figure 12. Global Acute Lung Injury Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Acute Lung Injury Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Acute Lung Injury Market Share by Regions: 2020 VS 2027
Figure 15. Global Acute Lung Injury Market Share by Regions (2022-2027)
Figure 16. Global Acute Lung Injury Market Share by Players in 2020
Figure 17. Global Top Acute Lung Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Lung Injury as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Acute Lung Injury Revenue in 2020
Figure 19. Global Acute Lung Injury Revenue Market Share by Type (2016-2021)
Figure 20. Global Acute Lung Injury Revenue Market Share by Type (2022-2027)
Figure 21. North America Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Acute Lung Injury Market Share by Type (2016-2027)
Figure 23. North America Acute Lung Injury Market Share by Application (2016-2027)
Figure 24. North America Acute Lung Injury Market Share by Country (2016-2027)
Figure 25. United States Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Acute Lung Injury Market Share by Type (2016-2027)
Figure 29. Europe Acute Lung Injury Market Share by Application (2016-2027)
Figure 30. Europe Acute Lung Injury Market Share by Country (2016-2027)
Figure 31. Germany Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Acute Lung Injury Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Acute Lung Injury Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Acute Lung Injury Market Share by Region (2016-2027)
Figure 41. China Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Acute Lung Injury Market Share by Type (2016-2027)
Figure 49. Latin America Acute Lung Injury Market Share by Application (2016-2027)
Figure 50. Latin America Acute Lung Injury Market Share by Country (2016-2027)
Figure 51. Mexico Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Acute Lung Injury Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Acute Lung Injury Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Acute Lung Injury Market Share by Country (2016-2027)
Figure 57. Turkey Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Acute Lung Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Altor BioScience Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 61. FirstString Research Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 63. Forschung und Entwicklung Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 64. Commence Bio Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 65. CompleGen Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 66. Histocell S.L. Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 67. Stemedica Cell Technologies Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 68. Windtree Therapeutics Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 69. S-Evans Biosciences Revenue Growth Rate in Acute Lung Injury Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---